2023
DOI: 10.1007/s13205-022-03445-3
|View full text |Cite
|
Sign up to set email alerts
|

Development of 9-(N-arylmethylamino) congeners of noscapine: the microtubule targeting drugs for the management of breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…Previous investigations disclosed that noscapine and its analogues induced apoptosis in many tumor cell types. , To determine whether the induction of apoptosis is responsible for the antiproliferative property of noscapine analogues, we assessed the induction of apoptosis in 4T1 mammary carcinoma tumor cells using annexin V and propidium iodide (PI) staining. As indicated in Figure , the percentage of cells undergoing apoptosis was 33.3% in noscapine-treated cells.…”
Section: Resultsmentioning
confidence: 99%
“…Previous investigations disclosed that noscapine and its analogues induced apoptosis in many tumor cell types. , To determine whether the induction of apoptosis is responsible for the antiproliferative property of noscapine analogues, we assessed the induction of apoptosis in 4T1 mammary carcinoma tumor cells using annexin V and propidium iodide (PI) staining. As indicated in Figure , the percentage of cells undergoing apoptosis was 33.3% in noscapine-treated cells.…”
Section: Resultsmentioning
confidence: 99%